NetScientific PLC New CEO appointed to Wanda
December 20 2016 - 2:00AM
RNS Non-Regulatory
TIDMNSCI
NetScientific PLC
20 December 2016
("NetScientific" or the "Company" or the "Group")
Foad Dabiri Appointed CEO of Portfolio Company, Wanda
London, UK - 20 December 2016 - NetScientific plc
("NetScientific", AIM:NSCI), the transatlantic healthcare IP
commercialisation Group, announces that Foad Dabiri has been
appointed Chief Executive Officer of its portfolio company Wanda to
take the company through its commercialisation phase. Foad takes
over with immediate effect from Steve Curd who has been Chief
Executive Officer since September 2015 and will step down as Chief
Executive Officer.
Foad Dabiri has been the Chief Technology Officer of Wanda since
March 2014, where he has been instrumental in creating Wanda's
unique cloud based platform for the management of chronic disease
management and is uniquely placed to lead Wanda as it moves into
commercialisation. Before joining Wanda, Foad was a Senior Software
Engineer at Google Inc for three years. He has also worked as
Principle Scientist at NetSeer Inc. Mr. Dabiri gained a PhD and
M.S. in Computer Science at the University of California and, prior
to that, was awarded a BS in Electrical Engineering from the Sharif
University of Technology.
Commenting on the news, François R. Martelet, Chief Executive
Officer of NetScientific and Chairman of Wanda, said: "Foad's
unique understanding of the nexus between predictive analytics,
data and patient need, make him the best person to lead Wanda at
this critical juncture as it moves into its commercialisation
phase. We are excited that he will be bringing his rare combination
of skills to the company and look forward to working with him.
I would like to thank Steve Curd for his contribution to the
Company during the early years and wish him all the best in the
future."
Foad Dabiri, incoming Chief Executive Officer of Wanda, said:
"We have seen first-hand the power of Wanda's predictive analytic
capabilities in managing the health of people with chronic disease
through our initial client base. Wanda's potential has become a
reality and I am delighted to have been appointed to lead the
company as it brings the platform to more and more patients and
builds its commercial reach."
- Ends -
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800
François R. Martelet,
M.D., CEO
Ian Postlethwaite, CFO
Consilium Strategic Tel: +44 (0)20 3709 5700
Communications netscientific@consilium-comms.com
Mary-Jane Elliott /
Jessica Hodgson / Chris
Welsh / Laura Thornton
About NetScientific Plc
NetScientific is a transatlantic healthcare technology group
with an investment strategy focused on sourcing, funding and
commercialising technologies that significantly improve the health
and well-being of people with chronic diseases. For more
information, please visit the website at www.netscientific.net
About Wanda
San Francisco-based Wanda is dedicated to advancing the
effectiveness and efficiency of medicine by using machine learning
in place of conventional technologies and by enabling clinicians to
make more informed care decisions. Wanda recognizes that remote
monitoring and algorithms cannot save lives or reduce
hospitalizations unless the individual and their caregivers are
promptly informed and highly engaged. Through the collaboration of
data science and applied medical research, Wanda has proven that
its inline analytics predict preventable events much better than
conventional methods. Wanda serves as a diligent companion,
providing encouragement and intelligent visual guidance that
simplifies and improves lives, while simultaneously helping
organizations reduce their care delivery costs. Wanda is a
NetScientific portfolio company. More information about Wanda can
be found at www.yourwanda.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAFESSSSFMSESE
(END) Dow Jones Newswires
December 20, 2016 02:00 ET (07:00 GMT)
Netscientific (LSE:NSCI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Netscientific (LSE:NSCI)
Historical Stock Chart
From Apr 2023 to Apr 2024